Patent 10052386 was granted and assigned to TherapeuticsMD on August, 2018 by the United States Patent and Trademark Office.
Various pharmaceutical formulations are disclosed herein. For example, a pharmaceutical formulation is disclosed comprising ultra-micronized progesterone.